Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group

OBJECTIVE

To assess the efficacy and toxicity of orally administered itraconazole in the treatment of nonmeningeal, nonlife-threatening forms of blastomycosis and histoplasmosis.

DESIGN

Prospective, nonrandomized, open trial.

SETTING

Multicenter trial at 14 university referral centers.

PATIENTS

Eighty-five patients with culture or histopathologic evidence of blastomycosis (48 patients) or histoplasmosis (37 patients). Patients receiving other systemic antifungal therapy were excluded.

INTERVENTIONS

Itraconazole was administered orally at doses of 200 to 400 mg/d. Patients in whom treatment was considered a success were treated for a median duration of 6.2 months (blastomycosis) and 9.0 months (histoplasmosis). Disease activity was assessed at baseline; drug efficacy and toxicity were evaluated at monthly intervals during therapy, and efficacy was evaluated at regular follow-up visits after completion of therapy. The median duration of posttreatment evaluation for successfully treated patients was 11.9 months (blastomycosis) and 12.1 months (histoplasmosis).

MEASUREMENTS AND MAIN RESULTS

Among the 48 patients with blastomycosis, success was documented in 43 (90%). The success rate for patients treated for more than 2 months was 95% (38 of 40). Among the 37 patients with histoplasmosis, success was documented in 30 (81%). The success rate for patients treated for more than 2 months was 86% (30 of 35). All patients with histoplasmosis in whom treatment failed had chronic cavitary pulmonary disease. Toxicity was minor; only 25 (29%) patients experienced any side effects, and itraconazole toxicity necessitated stopping therapy in only 1 patient.

CONCLUSIONS

Itraconazole is a highly effective therapy for nonmeningeal, nonlife-threatening blastomycosis and histoplasmosis. The drug is associated with minimal toxicity.

Current concepts in the management and prevention of tuberculosis in adults

After a steady decline in incidence during most of this century, tuberculosis case rates stabilized in the mid-1980s, and since then have steadily increased. Several factors may have been responsible for the increase, including the influx of immigrants from endemic areas and the appearance of AIDS. This review outlines the current recommendations for treatment of tuberculosis in the otherwise normal patient, then discusses special problems which may affect treatment, including primary drug failure and relapse, pregnancy and lactation, extrapulmonary disease, AIDS, renal failure, and liver disease. The appearance and significance of multiple-drug-resistant tuberculosis (MDRT) in AIDS victims is discussed, and current recommendations for screening patients for the presence of tuberculosis are reviewed.

Cavitary lung disease. How to read the radiographic patterns

Many disorders and abnormalities are accompanied by cavitary lesions of the lung, including various diseases that may destroy or replace lung tissue. The most common causes of cavitary lung disease are primary and metastatic neoplasms, granulomas, and necrotizing pulmonary infections. These diseases often have radiographic patterns, clinical signs, and symptoms that are characteristic and may suggest a diagnosis.

Incorrect use of metered dose inhalers by medical personnel

We administered a questionnaire and observed usage of a placebo metered dose inhaler (MDI) among 35 physicians, 14 nurses, and 12 respiratory therapists. Ninety-two percent of the respiratory therapists performed at least four of seven steps correctly, compared with 65 percent of house staff physicians, 57 percent of nurses, and 50 percent of nonpulmonary faculty. Most participants followed package insert instructions, while only 18 percent followed recent recommendations for proper MDI use. We conclude that (1) medical personnel should have additional instruction in proper MDI usage and (2) respiratory therapists and nurses can play a prominent role in instructing patients in their proper use.

Respiratory syncytial virus infection among intubated adults in a university medical intensive care unit

Respiratory syncytial virus is the major cause of lower respiratory tract infection in children. Adults who are immunocompromised, aged, institutionalized, and/or have underlying medical diseases may be at risk for severe RSV infection. Intubated adults in an MICU were evaluated for evidence of RSV infection. Respiratory secretions were analyzed by cell culture and RSV EIA. Serologic testing was obtained. Respiratory secretions from MICU personnel with acute respiratory symptoms and patients admitted for pneumonia, asthma, or COPD also were screened. Five of 11 intubated patients had evidence of RSV infection. One of seven MICU employees and four of 48 ward patients had RSV-positive respiratory secretions. During community outbreaks of RSV infection, adults admitted to an MICU already may be infected with RSV; those admitted for other reasons are at risk for nosocomial infection. Patients occupying other hospital units and personnel may be instrumental in the nosocomial dissemination of RSV.

Patient reading ability: an overlooked problem in health care

Health care workers often assume that patients who have completed a certain grade in school can read at that level. This study examines the relationships between patient reading ability, the last grade completed, and the reading ability necessary to comprehend commonly used written materials. We tested 528 patients during regular visits to seven outpatient clinics serving a predominantly indigent population. In addition, we analyzed the readability of 280 brochures and consent forms used in these clinics. Most patients had reading abilities on a level far below their last grade completed, while almost all materials tested were written on a level far above average patient reading ability. We conclude that patient reading ability should be routinely tested and that written materials should be developed on a level commensurate with patient reading ability.

Rapid assessment of literacy levels of adult primary care patients

Health education materials, medical instructions, consent forms, and self-report questionnaires are often given to patients with little regard for their ability to read them. Reading ability is rarely tested in medical settings. The Rapid Estimate of Adult Literacy in Medicine (REALM) was developed as a quick screening tool to assist physicians in identifying patients with limited reading skills and in estimating patient reading levels. This information can be used to tailor materials and instructions to patients' abilities. The REALM and the reading sections of the Peabody Individual Achievement Test-Revised and the Slosson Oral Reading Test were used to test reading ability in 207 adults in six public and private primary care clinics. REALM scores correlated highly with those of the standardized reading tests. The REALM, which takes three to five minutes to administer and score, appears to be a practical instrument to estimate patient literacy in primary care, patient education, and medical research.

Nebulized atropine sulfate in the treatment of acute asthma

Conflicting reports have appeared concerning the role of anticholinergic agents in the treatment of acute asthma. This study was designed to determine whether atropine sulfate, the only anticholinergic agent currently available in the United States for nebulization, increases bronchodilation when added to an inhaled beta-adrenergic agonist during the initial treatment of an acute asthma attack. Adults asthmatics (n = 40) with acute asthma attacks were randomized to receive metaproterenol (5 percent solution, 0.3 ml) either alone or with atropine sulfate (2.5 mg), by nebulization. Spirometry, vital signs, and the presence of side effects 0, 30, 60, and 120 minutes after treatment were determined. There were no significant differences between the metaproterenol alone and metaproterenol plus atropine sulfate groups in regard to age, duration of asthma, baseline spirometry, or side effects. No differences were noted between the two groups regarding changes in FEV1 and FVC from baseline (expressed in milliliters or as a percentage of baseline) during the observation period. We conclude that nebulized atropine sulfate yields no additional benefit when added to metaproterenol during the initial treatment of an acute asthma attack.

Treatment with acyclovir of varicella pneumonia in pregnancy

Varicella pneumonia during pregnancy carries a significant mortality for both mother and fetus. The antiviral drug, acyclovir, appears to have decreased mortality in reported cases. We present a case report and review of the literature summarizing the experience to date with acyclovir in the treatment of varicella pneumonia during pregnancy.

Indications for spirometry in outpatients with respiratory disease

It has been suggested that spirometry should be incorporated into the routine examination of every patient, analogous to obtaining vital signs. To determine the impact of spirometry on the management of outpatients with respiratory disease, spirometry was performed on 150 consecutive patients (123 men and 27 women, mean age 57 +/- 12 years) seen in our pulmonary disease outpatient clinics. Patients with obstructive (n = 75), restrictive (n = 31), mixed (n = 26) or other respiratory diseases (n = 18) were initially assessed by history and physical examination and classified as improved, stable, or worse compared to previous visits. A clinical management plan (CMP) was formulated based on this initial evaluation. Spirometric results were then made available to the examiner who could then make changes in the proposed CMP. The addition of spirometric results caused alteration of the CMP in only eight (5 percent) patients; in the remaining 142 patients, results did not affect the CMP. Two clinical findings identified those patients whose CMP was most likely to be altered by spirometry: severity of lung dysfunction (determined from previous spirometry) and deterioration of clinical status (judged by history and physical examination). Of the eight patients whose CMP was changed after review of spirometry, six (75 percent) had previous severe ventilatory dysfunction (FEV1 or FVC less than or equal to 40 percent of predicted or FEV1/FVC ratio less than or equal to 0.40). In 6 of 38 patients (16 percent) with severe ventilatory dysfunction, CMP was altered after spirometry while only 2 of 112 patients (1.8 percent) with mild or moderate dysfunction had changes in their CMP. Patients who were clinically assessed as worse compared to their previous visit were more likely to have their CMP altered after review of spirometry when compared to those considered improved or stable by a ratio of 6:1. These results suggest that spirometry is most likely to supplement the physician's history and physical examination in the management of outpatients with pulmonary disease when the initial evaluation suggests that the patient has clinically deteriorated since the previous clinic visit, or when he or she has previous severe ventilatory dysfunction.

Bronchial asthma

Asthma is one of the most common respiratory problems in modern industrialized countries, affecting over 5% of the population. It affects all age groups from infants to senior citizens, and mortality rates from asthma appear to be increasing during the past few years in the United States as well as in other industrialized countries. Asthma tends to occur in families, associated with other allergic disease, and may be induced by a wide variety of environmental antigens, most commonly inhaled allergens such as pollen and dust. Bronchial challenge with a specific allergen results in an early bronchospastic response with a relatively brief duration, and in a significant number of patients there is a late response with onset after 3 to 4 hours, lasting hours to days. This late response is associated with a bronchial hypersensitivity reaction, which is demonstrable by nonspecific challenge testing in the laboratory. During the period of bronchial hyperresponsiveness patients are prone to develop attacks following exposure to a wide variety of "triggers," including cold air, fumes, or cigarette smoke. The current approach to management of patients with asthma emphasizes prevention, with avoidance of specific allergens when possible, and chronic use of anti-inflammatory agents including corticosteroids and cromolyn sodium. The goal is to decrease the bronchial hyperresponsiveness. Management of the acute asthma attack consists of bronchodilator therapy, primarily with inhaled beta-adrenergic agonists, and administration of oral or systemic corticosteroids if the attack is not rapidly relieved. Additional therapeutic agents including theophylline and anticholinergics may be useful in some situations. Response to therapy during the first couple of hours in the emergency room is the most important predictor of the course of the acute attack, and patients who have not responded significantly after 2 hours of maximum therapy are candidates for hospital admission or prolonged emergency room observation. The goal of acute therapy is to wean the patient from intravenous drugs and place him or her on rapidly tapering doses of oral prednisone while initiating a vigorous program of preventive therapy. Follow-up observation, both in the office and in the patient's home, is vital and involves extensive patient education and objective testing of peak airflow. In general, the course of asthma is relatively benign compared with other obstructive airway diseases; however, significant mortality exists, especially in older patients and those with late-onset asthma.

Significance of false-positive serologic tests for histoplasmosis and blastomycosis in an endemic area

False-positive serologic tests for histoplasmosis (H) and blastomycosis (B) are common in populations from endemic areas. In order to determine the significance of false-positive test results, we reviewed the final diagnoses of all patients whose sera were submitted to our laboratory for radioimmunoassay (RIA) and immunodiffusion (ID) during a 3-yr period. Of the 263 patients whose sera were examined, 29 (11%) had H or B; 41 (17.5%) of the remaining 234 patients had false-positive test results. Of these 41 patients, 31 were positive for H alone, and 10 had antibodies to both H and B. All three patients with false-positive ID tests for histoplasmosis also had positive titers (greater than or equal to 1:16) on RIA. No patient had a false-positive ID result for blastomycosis. The percentage of patients in each of five major diagnostic categories with and without false-positive serologic tests was similar (p greater than 0.05). The majority of patients had pulmonary infections, almost half of which were granulomatous infections other than H or B; this reflects the clinical indications for requesting fungal serologic tests. A positive fungal serology is not useful in suggesting the presence of a pulmonary disease other than H or B in patients from an endemic area suspected of having a pulmonary mycosis.

Comparison of tracheal aspirates and protected brush catheter specimens for identifying pathogenic bacteria in mechanically ventilated patients

Bacterial respiratory infections are common in patients undergoing prolonged mechanical ventilation, and antibiotic selection often is based upon the results of smears and cultures of tracheal aspirates (TA). This study was designed to determine the reliability of gram stains, cultures and antibody-coating of bacteria in TA by comparing them with the results of quantitative cultures of specimens obtained by protected brush catheters (PBC) inserted into involved areas of lung parenchyma. Twenty-two patients on mechanical ventilation for at least 72 hours, with new radiographic infiltrates and fever, were studied. Tracheal aspiration was performed in the usual manner using sterile disposable kits. Immediately thereafter, patients underwent fiberoptic bronchoscopy, and PBC-specimens were obtained from the areas of new radiographic infiltrates. Tracheal aspirates were gram stained and cultured aerobically, and antibody coating of bacteria was determined by fluorescence microscopy. Quantitative culture of PBC specimens contained greater than or equal to 10(3) colony forming units per brush in 16 of the 22 patients; a smaller number of organisms was present in two additional patients. In TA from all 22 patients, gram stains revealed polymorphonuclear neutrophils and bacteria. Cultures of TA revealed potential pathogens in 20 patients, and in 15, multiple pathogens were present. The bacteria isolated from PBC also were present in 14 of the 16 patients with greater than or equal to 10(3) CFU in PBC cultures (88%). Antibody coating was present in TA from 12 patients, and antibody coating correlated poorly with cultures of PBC specimens.(ABSTRACT TRUNCATED AT 250 WORDS)

Late dissemination of pulmonary blastomycosis during ketoconazole therapy

We report a patient with pulmonary blastomycosis who suffered relapse with dissemination of her disease after five months of apparent response to therapy with ketoconazole, 400 mg daily. Common causes of drug failure, including noncompliance and failure of absorption, were excluded, and there was no evidence of altered host immunity. Previous reports of relapse during and after ketoconazole therapy are reviewed; no previous case was found with recurrence near the end of a six-month period of apparently effective therapy. Close followup during the entire course of ketoconazole therapy for blastomycosis and following its completion is recommended.

Fungal diseases of the pleura: clinical manifestations, diagnosis, and treatment

Fungal respiratory infections were once considered rare and limited to certain endemic areas in the southeastern United States or the western desert areas. With the development and increasing use of agents that alter host immunity, as well as the spread of human immune deficiency virus infections in this country, the incidence and clinical features of fungal infections are changing. Opportunistic fungi, ubiquitous in our environment, have become common infectious agents in hospitalized patients. The pathogenic fungi are no longer considered to be limited to certain geographic areas because of the increased mobility of the population and reports of infections outside the usual endemic areas. Both opportunistic and pathogenic fungi may infect the pleural space, and symptoms of pleural disease may be the presenting complaint in patients with respiratory mycoses. This review summarizes the common clinical findings in fungal infections of the pleura, including those findings that suggest a fungal etiology. Diagnostic studies used to define the etiologic agent and recommended therapeutic approaches are also discussed.

Use of respiratory care procedures in the management of hospitalized asthmatics

The current management of the hospitalized asthmatic includes a number of respiratory therapy techniques, both diagnostic and therapeutic. These include measures to increase arterial oxygen content, monitoring of gas exchange, administration of bronchodilator aerosols, chest physiotherapy techniques, breathing exercises, and mechanical ventilation. While many of these are potentially helpful, some are misused or are not of proven benefit. This review is designed to acquaint the clinician with the procedures commonly used, their potential benefits, or lack thereof, and their possible hazards. Recommendations are given for the rational use of these techniques, based upon the experience of the authors.

Large fluid-filled thoracic mass in a young man

As this case illustrates, lung cancer should be included in the differential diagnosis in a young person with fever, purulent sputum, and a large cystic mass on chest roentgenogram. An aggressive diagnostic approach including biopsy is recommended if symptoms do not respond to early treatment.

Pulmonary mycoses. New concepts and new therapy

The pathogenic and opportunistic fungi that commonly infect the human respiratory system cause diseases such as histoplasmosis, blastomycosis, aspergillosis, and invasive candidiasis. The increase in the incidence and severity of mycotic infections due to more aggressive immunosuppressive therapy and the spread of acquired immunodeficiency syndrome (AIDS) has had an impact on diagnosis and treatment of these conditions. Several therapeutic agents are currently available or undergoing clinical trials in the treatment of the pulmonary mycoses; among the agents with the greatest potential usefulness are the oral imidazoles, ketoconazole, itraconazole, and fluconazole.

Respiratory physical therapy in the treatment of chronic bronchitis

Currently recommended respiratory physical therapy procedures include measures designed to improve the clearance of secretions from the lungs, improve distribution of inspired air, and improve the general physical condition. In patients with chronic bronchitis there is frequently an abundance of thick, tenacious bronchial secretions associated with defective mucociliary function due to diffuse disease of the airways. Those who are unable to clear their secretions adequately are candidates for one or more of the techniques discussed here. In designing a treatment plan for the chronic bronchitic, it is important to use only those techniques with demonstrated benefit and minimal hazard in that particular patient.

Influence of spirometry and chest roentgenography on the management of pulmonary outpatients

Spirometry and chest roentgenography are frequently employed to evaluate patients with respiratory problems. To determine their impact on the management of outpatients with lung disease, both tests were performed on 100 consecutive patients (40 men and 60 women; mean age, 52 +/- 15 years) who returned for reevaluation 16 +/- 9 weeks after their previous clinic visit. Patients with obstructive (n = 45), restrictive (n = 35), and mixed (n = 20) lung diseases were initially assessed by history and physical examination and classified clinically as improved, stable, or worse. A clinical management plan (CMP) was formulated based on this initial evaluation. Changes in the proposed CMP due to spirographic or roentgenographic results were then noted. None of the 19 patients who were clinically improved and only two (3%) of the 64 clinically stable patients had a change in CMP. In contrast, five (29%) of the 17 patients whose conditions deteriorated clinically had their proposed CMP modified after review of the spirograms and roentgenograms. Therapy was intensified in three of the seven patients whose CMPs were modified, while in the other four, treatment was withheld because results of both tests were unchanged. These results indicate that routine spirograms and chest films have little influence on the CMP of clinically stable patients. However, unexpected roentgenographic and spirometric findings frequently alter the management of the individual whose condition has clinically deteriorated.

Evaluation of enzyme immunoassay as a rapid screening test for histoplasmosis and blastomycosis

This study evaluates the usefulness of enzyme immunoassay (EIA) as a screening test for serum antibodies to Histoplasma capsulatum and Blastomycoses dermatitidis and compares the results using this assay with those using complement fixation (CF), immunodiffusion (ID), and radioimmunoassay (RIA), in 12 patients with active histoplasmosis, 12 with active blastomycosis, 28 with other acute or chronic lung diseases and 25 healthy blood donors from an endemic area; EIA was as sensitive as RIA and more sensitive than CF and ID in the 24 patients with active fungal infections. The specificity of EIA was equal to that of the other serologic tests. We conclude that EIA is a useful screening test for serum antibodies to H. capsulatum and B. dermatitidis that avoids some of the problems associated with other sensitive assays such as RIA. A negative EIA result is evidence against invasive histoplasmosis or blastomycosis and suggests an alternative diagnosis.